DURECT Form 4: Director R. Scott Asen Purchases 204K Shares
Rhea-AI Filing Summary
R. Scott Asen, a director of DURECT Corp (DRRX), reported purchases of the company's common stock on August 20-21, 2025. The filings show he acquired 87,608 shares on 08/20/2025 at $1.8875 per share and 116,612 shares on 08/21/2025 at $1.8978 per share. Following the reported transactions, the Form indicates beneficial ownership figures of 970,000 shares (reported as indirect) and 2,666,612 shares (reported as direct) after the respective transactions. The filing also discloses that Mr. Asen is deemed beneficial owner of 30,000 shares through The Asen Foundation and 940,000 shares indirectly as President of Asen & Co., which provides advisory services and holds voting and dispositive power for certain managed accounts. The reporting person signed the Form on 08/22/2025.
Positive
- Director purchases shares totaling 204,220 shares across 08/20/2025 and 08/21/2025, indicating insider accumulation.
- Complete disclosure of transaction dates, share amounts, prices, and beneficial ownership sources (Foundation and Asen & Co.).
Negative
- None.
Insights
TL;DR: A company director made two open-market purchases totaling 204,220 shares at roughly $1.89, increasing reported direct and indirect holdings.
The transactions are straightforward purchases reported on Form 4, showing active insider accumulation across two consecutive days. The split between indirect and direct beneficial ownership is clarified in the explanatory footnote: 30,000 shares via a foundation and 940,000 shares via advisory-managed accounts, while the post-transaction totals reported are 970,000 (indirect) and 2,666,612 (direct) on the respective lines. For investors, such purchases by a director are a disclosed insider activity but the filing contains no further financial or operational context about DURECT Corp.
TL;DR: Governance disclosure is complete for these transactions and identifies the reporting person nd indirect ownership sources.
The Form 4 clearly identifies the reporting person, relationship to the issuer, transaction dates, quantities, prices, and the nature of indirect ownership. The explanation notes trustee authority over a foundation and advisory powers through Asen & Co., with a standard disclaimer of beneficial ownership except for pecuniary interest. No amendments or plans (e.g., Rule 10b5-1) are indicated. From a governance perspective, the filing meets Section 16 disclosure requirements and provides investors with necessary transparency on the director nd related-party holdings.